About 10 results found for searched term "Glucokinase (GK)" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3562 | LY2608204 | Glucokinase (GK) |
| Globalagliatin | ||
| LY2608204 activates glucokinase (GK) with EC50 of 42 nM. | ||
| M7567 | AM2394 | Glucokinase (GK) |
| AM-2394 is a structurally distinct glucokinase activator (GKA). AM-2394 activates glucokinase (GK) with an EC50 of 60 nM. | ||
| M10047 | Dorzagliatin | Glucokinase (GK) |
| HMS5552; RO5305552; Sinogliatin | ||
| Dorzagliatin (HMS-5552, RO-5305552, Sinogliatin) is a glucokinase (GK) activator, which improves glycaemic control and pancreatic β-cell function for type 2 diabetes. | ||
| M10305 | AZD1656 | Glucokinase (GK) |
| AZD-1656 | ||
| AZD1656 is a potent, selective and orally active glucokinase (GK) activator, with an EC50 of 60 nM. | ||
| M14437 | RO-28-1675 | Glucokinase (GK) |
| RO-28-1675 is a potent allosteric glucokinase (GK) activator with an EC50 of 54 nM. RO-28-1675 can be used for the research of type 2 diabetes. | ||
| M21065 | BMS-820132 | Others |
| BMS-820132 is an oral glucokinase (GK) partial activator for the study of diabetes mellitus. the AC50 is 29 nM. | ||
| M21626 | Cadisegliatin (TTP-399) | Glucokinase (GK) |
| TTP-399 | ||
| Cadisegliatin (TTP-399) is a potential, orally active liver-selective glucokinase (GK) activator. Cadisegliatin has antihyperglycaemic activity. Cadisegliatin can be used for the research of type 2 diabetes. | ||
| M31409 | TMG-123 | Glucokinase (GK) |
| TMG-123 is a glucokinase (GK) activator that can be used in studies related to type 2 diabetes. | ||
| M31411 | GKM-001 | Glucokinase (GK) |
| GKM-001 is a glucokinase (GK) activator that can be used in studies related to type 2 diabetes. | ||
| M42408 | AZD1092 | Glucokinase (GK) |
| AZD1092 is an orally active glucokinase (GK) activator with an EC50 value of 0.03 μM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
